Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

NCT05314231 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Alexion Pharmaceuticals, Inc.